New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Legend Biotech Corporation
LEGN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8B

Biotechnology

Next Earning date - 18 Nov 2024

8B

Biotechnology

Next Earning date - 18 Nov 2024

44.99USD
Shape0.09 ( 0.19%)
Market Open
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-98%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated October 16, 2024
1W -10.64 % 1M -12.23 % 3M -18.35 % 1Y -33.68 %

Key Metrics

Shape
  • Market Cap

    8.24B


  • Shares Outstanding

    183.17M


  • Share in Float

    181.45M


  • Dividende

    0


  • Earning Date

    18 Nov 2024


  • Price Target

    44.995


  • Average Volume

    889510


  • Beta

    0.098


  • Range

    38.6-70.13


  • Industry

    Biotechnology


  • Website

    https://www.legendbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

18.04x

P/S Ratio

7.08x

P/B Ratio

0.3

Debt/Equity

-62.5%

Net Margin

$-1.5

EPS

How LEGN compares to sector?

P/E Ratio

Relative Strength

Shape

LEGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape447%

2025-Revenue

$1.19

Shape-1094%

2025-EPS

$1B

Shape-2688%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Deutsche Bank

initialise

Previous: Not converted

2024-05-23

Now: Buy

Scotiabank

upgrade

Previous: Sector Perform

2024-04-17

Now: Outperform

Cantor Fitzgerald

initialise

Previous: Not converted

2024-04-03

Now: Overweight

William Blair

initialise

Previous: Not converted

2023-05-25

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.27
vs -0.43

Q4.22

arrow
arrow

N/A

-0.41
vs -0.38

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-0.27
vs NA

Q3.23

arrow
arrow

N/A

NA
vs -0.27

Q4.23

arrow
arrow

N/A

-0.40
vs -0.41

Q1.24

arrow
arrow

N/A

-0.16
vs NA

Q2.24

arrow
arrow

N/A

-0.05
vs -0.27

Q3.24

arrow
arrow

N/A

-0.34
vs NA

Q4.24

arrow
arrow

N/A

-0.31
vs -0.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+62%

27.4M  vs 16.9M

Q4.22

arrow
arrow

-29%

27.6M  vs 39M

Q1.23

arrow
arrow

-11%

36.3M  vs 40.8M

Q2.23

arrow
arrow

+513%

73.3M  vs 12M

Q3.23

arrow
arrow

+251%

96M  vs 27.4M

Q4.23

arrow
arrow

+188%

79.5M  vs 27.6M

Q1.24

arrow
arrow

+159%

94M  vs 36.3M

Q2.24

arrow
arrow

+154%

186.5M  vs 73.3M

Q3.24

arrow
arrow

+42%

136.1M  vs 96M

Q4.24

arrow
arrow

+115%

170.9M  vs 79.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-11%

-0.11
vs -0.34

Q4.22

arrow
arrow

-18%

-0.18
vs -0.11

Q1.23

arrow
arrow

-17%

-0.17
vs -0.18

Q2.23

arrow
arrow

-14%

-0.14
vs -0.17

Q3.23

arrow
arrow

-5%

-0.05
vs -0.14

Q4.23

arrow
arrow

-12%

-0.12
vs -0.05

Q1.24

arrow
arrow

-5%

-0.05
vs -0.12

Q2.24

arrow
arrow

-2%

-0.02
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

169

169
vs 160

6%

Q4.22

arrow
arrow

181

181
vs 169

7%

Q1.23

arrow
arrow

170

170
vs 181

-6%

Q2.23

arrow
arrow

202

202
vs 170

19%

Q3.23

arrow
arrow

216

216
vs 202

7%

Q4.23

arrow
arrow

227

227
vs 216

5%

Q1.24

arrow
arrow

211

211
vs 227

-7%

Q2.24

arrow
arrow

186

186
vs 211

-12%

Earnings Growth

Latest News